{"transactions":[{"id":1835750,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO"}}],"security":"Common Stock","published_at":"2023-07-05T20:05:07.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":167,"price":1.5895,"value":265.4465,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\")."}],"balance_after":3671,"source":{"system":"sec-edgar","filing":"0001415889-23-010719","document":"form4-07052023_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588923010719/form4-07052023_040701.xml","form_type":"4"}},{"id":2072467,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2023-01-03T21:11:11.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":5000,"price":0.0876,"value":438.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\")."}],"balance_after":105111,"source":{"system":"sec-edgar","filing":"0001415889-23-000043","document":"form4-01032023_090100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588923000043/form4-01032023_090100.xml","form_type":"4"}},{"id":2206875,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2022-07-15T20:30:54.000Z","date":"2022-07-30","kind":"grant","acquired":true,"shares":5000,"price":0.748,"value":3740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes shares held by the Reporting Person as of the date of this Form 4, but inadvertently excluded from previously filed reports."}],"balance_after":100111,"source":{"system":"sec-edgar","filing":"0001415889-22-007686","document":"form4-07152022_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922007686/form4-07152022_040701.xml","form_type":"4"}},{"id":2353757,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:17:16.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan.  Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":1.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-22-002300","document":"form4-03032022_010304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922002300/form4-03032022_010304.xml","form_type":"4"}},{"id":2436709,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T22:21:47.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this stock option vested May 23, 2019, with the the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter."}],"balance_after":15625,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":34375},"source":{"system":"sec-edgar","filing":"0001415889-22-000507","document":"form4-01122022_020137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922000507/form4-01122022_020137.xml","form_type":"4"}},{"id":2436708,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2022-01-12T22:21:47.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":18750,"price":1,"value":18750.0,"ownership":{"direct":true},"balance_after":94571,"source":{"system":"sec-edgar","filing":"0001415889-22-000507","document":"form4-01122022_020137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922000507/form4-01122022_020137.xml","form_type":"4"}},{"id":2454096,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2022-01-03T21:20:34.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":3575,"price":1.6575,"value":5925.5625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)"}],"balance_after":75821,"source":{"system":"sec-edgar","filing":"0001415889-22-000041","document":"form4-01032022_010120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922000041/form4-01032022_010120.xml","form_type":"4"}},{"id":2575823,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2021-09-08T22:58:15.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":30000,"price":3.125,"value":93750.0,"ownership":{"direct":true},"balance_after":72786,"source":{"system":"sec-edgar","filing":"0001415889-21-004287","document":"form4-09082021_030907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921004287/form4-09082021_030907.xml","form_type":"4"}},{"id":2644255,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":9824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent (25%) of the total number of shares began vesting  immediately on April 23, 2020, with the remaining shares vesting in 1/24th monthly installments thereafter."}],"balance_after":140176,"derivative":{"exercise_price":0.398,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2644254,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":78918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this stock option vested May 23, 2019, with the  the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter."}],"balance_after":34375,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":113293},"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2644253,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"disposition_to_issuer","acquired":false,"shares":36707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents stock options that were cancelled and returned to the Issuer in order to pay the exercise price associated with the exercise reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this stock option vested May 23, 2019, with the  the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter."}],"balance_after":113293,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2644252,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2023-10-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2644251,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":9824,"price":0.398,"value":3909.952,"ownership":{"direct":true},"balance_after":102786,"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2644250,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":78918,"price":1,"value":78918.0,"ownership":{"direct":true},"balance_after":92962,"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2644249,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":1000,"price":1.5,"value":1500.0,"ownership":{"direct":true},"balance_after":14044,"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2644248,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2021-07-02T20:10:59.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":3044,"price":1.9465,"value":5925.146,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":13044,"source":{"system":"sec-edgar","filing":"0001415889-21-003391","document":"form4-07022021_040729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921003391/form4-07022021_040729.xml","form_type":"4"}},{"id":2925399,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T21:57:26.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":1.77,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-21-000018","document":"form4-01042021_010114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921000018/form4-01042021_010114.xml","form_type":"4"}},{"id":2925398,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2021-01-04T21:57:26.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":5000,"price":0.4521,"value":2260.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on December 31, 2020 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-21-000018","document":"form4-01042021_010114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921000018/form4-01042021_010114.xml","form_type":"4"}},{"id":3095087,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Common Stock","published_at":"2020-07-01T21:28:50.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":5000,"price":0.448,"value":2240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan (\"ESPP\") on June 30, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-20-001765","document":"form4-07012020_020708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588920001765/form4-07012020_020708.xml","form_type":"4"}},{"id":3169003,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T21:10:56.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on April 23, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":0.398,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-20-001067","document":"form4-04272020_050442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588920001067/form4-04272020_050442.xml","form_type":"4"}},{"id":3389707,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-22T21:02:50.000Z","date":"2019-10-21","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":150000,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-21","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-19-001215","document":"form4-10222019_051046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919001215/form4-10222019_051046.xml","form_type":"4"}},{"id":3510177,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T20:09:18.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option reported herein shall vest on Vesting Start Date May 23, 2019, and 1/36th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":150000,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-19-000583","document":"form4-05282019_010505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919000583/form4-05282019_010505.xml","form_type":"4"}},{"id":3828591,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":100000,"derivative":{"exercise_price":1.5,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828590,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":0,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828589,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":50000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828588,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828587,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests periodically over a period of four years commencing 6/19/2016."}],"balance_after":75000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828586,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests periodically over a period of four years commencing 6/19/2016."}],"balance_after":0,"derivative":{"exercise_price":3.49,"expiration_date":"2026-06-19","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828585,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1000,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2023-10-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828584,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reporting person agreed to cancellation of an option granted to him on 10/27/2013 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":8,"exercise_date":"2015-10-27","expiration_date":"2023-10-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828583,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":4323,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4323,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2022-10-30","underlying":"Common Stock","underlying_shares":4323},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828582,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":4323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person agreed to cancellation of an option granted to him on 10/30/2012 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2014-10-30","expiration_date":"2022-10-30","underlying":"Common Stock","underlying_shares":4323},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828581,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":678,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":678,"derivative":{"exercise_price":1.5,"exercise_date":"2018-08-29","expiration_date":"2022-10-30","underlying":"Common Stock","underlying_shares":678},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3828580,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:25:46.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person agreed to cancellation of an option granted to him on 10/30/2012 in exchange for a new option having a lower exercise price."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2012-10-30","expiration_date":"2022-10-30","underlying":"Common Stock","underlying_shares":678},"source":{"system":"sec-edgar","filing":"0001415889-18-001319","document":"form4-08312018_020831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001319/form4-08312018_020831.xml","form_type":"4"}},{"id":3851841,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-06T20:38:40.000Z","date":"2018-08-05","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.27,"expiration_date":"2028-08-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001224","document":"form4-08062018_010826.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001224/form4-08062018_010826.xml","form_type":"4"}},{"id":4076111,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T21:54:47.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":200000,"derivative":{"exercise_price":1.16,"expiration_date":"2028-02-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-18-000186","document":"form4-02052018_010234.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918000186/form4-02052018_010234.xml","form_type":"4"}},{"id":4204710,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-20T20:32:07.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date."}],"balance_after":100000,"derivative":{"exercise_price":1.56,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-17-001519","document":"form4-09202017_010956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588917001519/form4-09202017_010956.xml","form_type":"4"}},{"id":4341994,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-28T19:33:13.000Z","date":"2017-04-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-17-000682","document":"form4-04282017_120403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588917000682/form4-04282017_120403.xml","form_type":"4"}},{"id":4560577,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":111610,"kind":"person","name":"DOTSON JERROLD DUANE","position":1,"cik":"0001388853","reported_name":"DOTSON JERROLD DUANE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND SECRETARY"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-11T01:30:38.000Z","date":"2016-11-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest monthly over a period of three years commencing November 9, 2016."}],"balance_after":50000,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-16-007389","document":"form4-11102016_081129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588916007389/form4-11102016_081129.xml","form_type":"4"}}]}